In our group, the sensitivity of CEA, CA724, CA199, and CA125 in the GC patients with lymph node metastasis was only 12.75, 21.57, 23.53, and 15.69 %, respectively. The gene discussed is CEACAM5; the disease is metastatic malignant neoplasm in the lymph nodes.